Multiple Myeloma

A malignancy of mature PLASMA CELLS engaging in monoclonal immunoglobulin production. It is characterized by hyperglobulinemia, excess Bence-Jones proteins (free monoclonal IMMUNOGLOBULIN LIGHT CHAINS) in the urine, skeletal destruction, bone pain, and fractures. Other features include ANEMIA; HYPERCALCEMIA; and RENAL INSUFFICIENCY.

Also Known As:

Kahler Disease; Myeloma, Multiple; Myeloma-Multiple; Myelomatosis; Plasma Cell Myeloma; Cell Myeloma, Plasma; Cell Myelomas, Plasma; Disease, Kahler; Multiple Myelomas; Myeloma Multiple; Myeloma, Plasma Cell; Myeloma-Multiples; Myelomas, Multiple; Myelomas, Plasma Cell; Myelomas, Plasma-Cell; Myelomatoses; Plasma Cell Myelomas; Plasma-Cell Myeloma; Plasma-Cell Myelomas; Myeloma, Plasma-Cell

Neoplasms: 1324753
- Neoplasms by Histologic Type: 2
  - Plasma Cell Neoplasms: 225
    - Multiple Myeloma: 26492
Cardiovascular Diseases: 91362
- Vascular Diseases: 15138
  - Hemostatic Disorders: 250
    - Multiple Myeloma: 26492
Hemic and Lymphatic Diseases: 6
- Hematologic Diseases: 3366
  - Hemorrhagic Disorders: 702
    - Hemostatic Disorders: 250
      - Multiple Myeloma: 26492
  - Blood Protein Disorders: 17
    - Paraproteinemias: 3452
      - Multiple Myeloma: 26492
Immune System Diseases: 4321
- Immunoproliferative Disorders: 29
  - Lymphoproliferative Disorders: 4250
    - Multiple Myeloma: 26492
  - Paraproteinemias: 3452
    - Multiple Myeloma: 26492

G Migneco Selected Research

G Migneco Research Topics

Disease

Drug/Important Bio-Agent (IBA)